New Guidelines for Preventing Steroid-Induced Bone Loss: What Patients Need to Know

Who Needs Treatment?

The guidelines now recommend bone-protecting treatment for more people taking steroids. This includes adults over 40 at moderate to high risk of fractures, even if they're on low doses of steroids. Risk is assessed using factors like age, steroid dose, and bone density scans. The guidelines also address younger adults and children, emphasizing the importance of early prevention.

Treatment Options

Bisphosphonates remain the first-choice medication for most people. However, the guidelines now suggest considering teriparatide or denosumab for those at very high fracture risk. Calcium and vitamin D supplements are recommended for almost everyone on long-term steroids. Lifestyle changes like exercise and fall prevention are also emphasized.

Monitoring and Follow-up

The guidelines stress the importance of regular bone density scans to track bone health. They also recommend reassessing fracture risk annually for people on long-term steroid therapy. This allows doctors to adjust treatment as needed. The guidelines emphasize a personalized approach, recognizing that each patient's situation is unique.

Frequently Asked Questions

Key Takeaways

These updated guidelines aim to prevent more fractures by identifying and treating at-risk patients early.

Related Articles

• Glucocorticoid-Induced Osteoporosis: What You Need to Know
• Bisphosphonates: The First Line of Defense Against Steroid-Induced Bone Loss
• Teriparatide: Building Stronger Bones for High-Risk Steroid Users
• Are You at Risk for Steroid-Induced Bone Loss? Key Factors to Consider

References